Drivers for Uber and Lyft are ferrying patients to cancer care appointments, emergency rooms, kidney dialysis, and other medical visits.
Most RCC patients surveyed said telemedicine visits are comparable to in-person visits, but most oncology providers disagreed ...
Belzutifan has a “generally manageable” safety profile in patients with RCC, with a relatively low rate of treatment discontinuation.
Source: Getty Images Avelumab plus axitinib was associated with significantly longer progression-free survival than ...
Source: Getty Images ASCO-ONS standards for the administration of antineoplastic therapy provide a framework for ensuring ...
Source: Getty Images Researchers provided recommendations for managing hypertension, diarrhea, palmar-plantar erythrodysesthesia, and liver enzyme elevations in patients with renal cell carcinoma ...
Strengthening health care access and quality … will be paramount for improving clinical outcomes and slowing projected trends,” researchers wrote.
ALLO-316, a CD70-targeting CAR T-cell therapy, has demonstrated activity in patients with previously treated, advanced ccRCC.
Source: Getty Images Researchers identified a tumor cell-specific transcriptomic signature that appeared to be associated with treatment resistance and worse outcomes. The combination produced a ...
Source: Getty Images Improving survival rates for patients with sarcomatoid differentiation can be attributed to advances in immunotherapy, according to researchers. The overall survival rate at 5 ...
Source: Getty Images The combination of vidutolimod and nivolumab “stimulates a broad antitumor immune response,” according to researchers. Vidutolimod and nivolumab produced a major pathologic ...
Source: Shutterstock Researchers compared the nephrotoxicity of VEGF tyrosine kinase inhibitor (TKI) therapy alone, the combination of a VEGF TKI and an immune checkpoint inhibitor (ICI), and ICI-ICI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback